Getein Biotech: Nanjing Aiji has completed a reduction of 0.1314%
Getein Biotech announced that its shareholder Nanjing Aiji plans to cumulatively reduce its holdings by 666,600 shares through centralized bidding by August 15, 2025, with a reduction ratio of 0.1314%. The price range for the reduction is between 8.1 to 8.87 yuan per share, and the reduction period is from June 9, 2025, to September 9, 2025. After the reduction, the remaining shares held will be 16,881,200, accounting for 3.33%. This reduction plan has been fully implemented
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments